Free Trial

Nuvectis Pharma (NVCT) Institutional Ownership

Nuvectis Pharma logo
$7.59 +0.07 (+0.93%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$7.82 +0.24 (+3.10%)
As of 02/21/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)

Current
Institutional Ownership
Percentage
96.77%
Number of
Institutional Buyers
(last 12 months)
17
Total
Institutional Inflows
(last 12 months)
$2.96M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$378.54K
Get NVCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

NVCT Institutional Buying and Selling by Quarter

Nuvectis Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 Squarepoint Ops LLC19,071$103K0.0%N/A0.099%
2/17/2025 Two Sigma Investments LP18,570$100K0.0%-30.7%0.096%
2/17/2025 Millennium Management LLC29,698$161K0.0%-56.6%0.154%
2/17/2025 Cubist Systematic Strategies LLC6,294$34K0.0%N/A0.033%
2/14/2025 Northern Trust Corp25,725$139K0.0%+68.7%0.133%
2/13/2025 Marshall Wace LLP124,571$674K0.0%+191.0%0.645%
2/12/2025 Edmond DE Rothschild Holding S.A.15,170$82K0.0%-20.9%0.079%
2/12/2025 Baxter Bros Inc.15,000$81K0.0%+20.0%0.078%
2/5/2025 Oppenheimer & Co. Inc.25,000$135K0.0%N/A0.129%
1/30/2025 Nations Financial Group Inc. IA ADV13,500$73K0.0%+35.0%0.070%
1/28/2025 Forbes J M & Co. LLP59,000$319K0.0%+21.9%0.305%
1/22/2025 Baldwin Wealth Partners LLC MA355,961$1.93M0.1%+104.4%1.842%
11/16/2024 Geode Capital Management LLC79,716$501K0.0%+49.8%0.413%
11/5/2024 GSA Capital Partners LLP50,129$315K0.0%+3.7%0.269%
11/5/2024 Nations Financial Group Inc. IA ADV10,000$63K0.0%N/A0.054%
10/25/2024 Iridian Asset Management LLC CT55,380$348K0.1%N/A0.297%
9/16/2024 Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050%
8/15/2024 Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050%
8/14/2024 Marshall Wace LLP33,868$214K0.0%-32.4%0.185%
8/9/2024 Renaissance Technologies LLC74,500$472K0.0%+20.7%0.406%
7/16/2024 Baxter Bros Inc.12,500$79K0.0%N/A0.068%
7/12/2024 Baldwin Brothers LLC MA168,630$1.07M0.1%+9.4%0.918%
5/10/2024 Vanguard Group Inc.298,800$2.45M0.0%+1.5%1.626%
4/18/2024 Blue Zone Wealth Advisors LLC14,350$118K0.0%N/A0.081%
2/12/2024 Edmond DE Rothschild Holding S.A.19,170$160K0.0%N/A0.111%
1/30/2024Strs Ohio6,200$51K0.0%+59.0%0.036%
1/8/2024 Baldwin Brothers LLC MA142,040$1.19M0.1%+22.0%0.820%
11/2/2023 Forbes J M & Co. LLP34,000$438K0.1%-49.3%0.197%
10/26/2023Strs Ohio3,900$50K0.0%+178.6%0.023%
10/10/2023 Baldwin Brothers LLC MA116,380$1.50M0.1%+29.2%0.675%
8/10/2023 Hollencrest Capital Management3,040$49K0.0%N/A0.019%
8/4/2023 American International Group Inc.3,298$53K0.0%N/A0.021%
8/3/2023 Forbes J M & Co. LLP67,000$1.07M0.1%N/A0.418%
8/2/2023 Bank of Montreal Can11,012$200K0.0%N/A0.069%
7/14/2023 Baldwin Brothers LLC MA90,061$1.44M0.1%-37.4%0.563%
5/11/2023 Edmond DE Rothschild Holding S.A.24,570$322K0.0%N/A0.167%
4/21/2023 Baldwin Brothers LLC MA143,800$1.89M0.2%+7.9%0.975%
11/4/2022Ronit Capital LLP562,547$3.99M5.4%+34.2%3.843%
10/14/2022 Baldwin Brothers LLC MA133,000$943K0.1%+9.9%0.908%
8/4/2022Ronit Capital LLP419,282$4.70M6.7%-23.8%3.297%
Buy this AI Stock Before Elon’s Announcement (Ad)

With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.

Click here to watch my presentation and learn how to invest today.
7/18/2022 Baldwin Brothers LLC MA121,000$1.36M0.2%N/A0.951%
5/11/2022Ronit Capital LLP550,000$4.08M5.1%N/A4.325%
(Data available from 1/1/2016 forward)

NVCT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NVCT shares?

During the previous two years, 24 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were Vanguard Group Inc. ($2.45M), Baldwin Wealth Partners LLC MA ($1.93M), Baldwin Brothers LLC MA ($1.07M), Marshall Wace LLP ($674K), Geode Capital Management LLC ($501K), Renaissance Technologies LLC ($472K), and Iridian Asset Management LLC CT ($348K).Learn more on NVCT's institutional investors.

What percentage of Nuvectis Pharma stock is owned by institutional investors?

96.77% of Nuvectis Pharma stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings.

Which institutional investors have been buying Nuvectis Pharma stock?

Of the 22 institutional investors that purchased Nuvectis Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baldwin Wealth Partners LLC MA ($181.83K), Marshall Wace LLP ($81.76K), Forbes J M & Co. LLP ($77.60K), Baldwin Brothers LLC MA ($76.98K), Iridian Asset Management LLC CT ($55.38K), Edmond DE Rothschild Holding S.A. ($43.74K), and Geode Capital Management LLC ($26.49K).

How much institutional buying is happening at Nuvectis Pharma?

Institutional investors have bought a total of 707,125 shares in the last 24 months. This purchase volume represents approximately $5.53M in transactions.

Which Nuvectis Pharma major shareholders have been selling company stock?

The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Baldwin Brothers LLC MA ($53.74K), Millennium Management LLC ($38.80K), Forbes J M & Co. LLP ($33K), Marshall Wace LLP ($16.20K), Two Sigma Investments LP ($8.22K), and Edmond DE Rothschild Holding S.A. ($4K).

How much institutional selling is happening at Nuvectis Pharma?

Institutional investors have sold a total of 153,955 shares in the last 24 months. This volume of shares sold represents approximately $1.66M in transactions.



This page (NASDAQ:NVCT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners